Related Experiment Video
Updated: Jan 20, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
The effect of P2X7R-mediated Ca2+ signaling in OPG-induced osteoclasts adhesive structure damage
Yonggang Ma1, Hongyan Zhao1, Chung Chile1
1College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu, 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety of the Ministry of Education of China, Yangzhou University, Yangzhou, Jiangsu, 225009, PR China.
Abstract:
Osteoclast adhesion is important for bone resorption. Osteoprotegerin inhibits osteoclast differentiation and bone resorption via Ca2+ signaling. Purinergic receptor P2X7 (P2X7R) affects osteoclastogenesis by activating transcription factor nuclear factor of activated T cells 1 (NFATc1). However, the detailed mechanism of osteoprotegerin-mediated P2X7R modulation of osteoclast adhesion is unclear. This study aimed to determine the effect of P2X7R on osteoprotegerin-induced damage to osteoclast adhesion. Osteoprotegerin reduced the expression of P2X7R, and protein tyrosine kinase 2 (PYK2) and SRC phosphorylation, and reduced calcium concentration, significantly decreasing Ca2+-NFATc1 signaling. 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM)/N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) partly or absolutely recovered osteoprotegerin-induced osteoclasts adhesion structure damage, including increased the PYK2 and SRC phosphorylation, changed the distribution of PYK2/SRC and integrinαvβ3, and inhibited retraction of lamellipodia and filopodia and recovered osteoclast bone resorption activity. In addition, BAPTA-AM/W-7 also increased osteoprotegerin-induced activation of Ca2+-NFATc1 signaling, and restored normal P2X7R levels. P2X7R knockdown significantly inhibited osteoclast differentiation, and the formation of lamellipodia and filopodia, reduced the PYK2 and SRC phosphorylation, and inhibited Ca2+-related protein activation. However, P2X7R knockdown aggravated osteoprotegerin-induced osteoclast adhesion damage via Ca2+ signaling. In conclusion, the P2X7R-Ca2+ NFATc1 signaling pathway has a key functional role in osteoprotegerin-induced osteoclast adhesion structure damage.
Insights
Osteoprotegerin impairs osteoclast adhesion by reducing P2X7R and calcium signaling. Restoring these pathways can reverse this damage, highlighting the P2X7R-Ca2+-NFATc1 pathway
Area of Science:
- Cell Biology
- Biochemistry
- Bone Biology
Background:
- Osteoclast adhesion is crucial for bone resorption, a process regulated by various signaling pathways.
- Osteoprotegerin (OPG) inhibits osteoclast differentiation and bone resorption, partly through calcium (Ca2+) signaling.
- Purinergic receptor P2X7 (P2X7R) influences osteoclastogenesis via nuclear factor of activated T cells 1 (NFATc1) activation, but its role in OPG-mediated effects on osteoclast adhesion is not fully understood.
Purpose of the Study:
- To investigate the role of P2X7R in OPG-induced damage to osteoclast adhesion structure.
- To elucidate the underlying molecular mechanisms involving Ca2+ signaling and downstream effectors.
Main Methods:
- Assessed the effects of OPG on P2X7R expression, PYK2 and SRC phosphorylation, and intracellular Ca2+ levels in osteoclasts.
- Utilized calcium chelators (BAPTA-AM/W-7) to examine their impact on OPG-induced osteoclast adhesion damage and signaling.
- Employed P2X7R knockdown to evaluate its specific contribution to osteoclast differentiation, adhesion, and signaling.
Main Results:
- OPG reduced P2X7R expression, PYK2/SRC phosphorylation, and Ca2+ concentration, impairing Ca2+-NFATc1 signaling and osteoclast adhesion.
- BAPTA-AM/W-7 treatment partially or fully restored osteoclast adhesion structure, PYK2/SRC phosphorylation, cytoskeletal dynamics, and bone resorption activity by enhancing Ca2+-NFATc1 signaling.
- P2X7R knockdown inhibited osteoclast differentiation and cytoskeletal organization but paradoxically exacerbated OPG-induced adhesion damage, indicating a protective role of P2X7R under OPG treatment.
Conclusions:
- The P2X7R-Ca2+-NFATc1 signaling pathway is critically involved in mediating OPG-induced damage to osteoclast adhesion structure.
- OPG-induced osteoclast dysfunction is linked to suppressed P2X7R and impaired Ca2+ signaling, affecting cytoskeletal integrity and bone resorption.
- Targeting the P2X7R-Ca2+-NFATc1 pathway may offer therapeutic strategies for bone diseases characterized by abnormal bone resorption.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Receptor-mediated Endocytosis
Osteoclasts in Bone Remodeling
Paracrine Signaling
What is Cell Signaling?

